Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 378.3 INR 0.83%
Market Cap: 246.9B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Relative Value

The Relative Value of one NATCOPHARM stock under the Base Case scenario is 868.33 INR. Compared to the current market price of 1 378.3 INR, Natco Pharma Ltd is Overvalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NATCOPHARM Relative Value
Base Case
868.33 INR
Overvaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
23
Median 3Y
4.6
Median 5Y
5.7
Industry
2.6
Forward
4.9
vs History
73
vs Industry
28
Median 3Y
18.5
Median 5Y
25.3
Industry
23
Forward
12.7
vs History
49
vs Industry
23
Median 3Y
20.1
Median 5Y
21.2
Industry
17.8
vs History
28
vs Industry
21
Median 3Y
22.5
Median 5Y
17
Industry
25.4
vs History
6
vs Industry
20
Median 3Y
3
Median 5Y
3.1
Industry
2.2
vs History
38
vs Industry
24
Median 3Y
4.3
Median 5Y
5.2
Industry
2.8
Forward
4.6
vs History
38
vs Industry
33
Median 3Y
5.7
Median 5Y
6.5
Industry
5.4
vs History
71
vs Industry
31
Median 3Y
13.2
Median 5Y
17.5
Industry
13.7
Forward
9.5
vs History
71
vs Industry
32
Median 3Y
15.6
Median 5Y
21.2
Industry
17.2
Forward
10.2
vs History
49
vs Industry
25
Median 3Y
18.9
Median 5Y
19.9
Industry
16.5
vs History
31
vs Industry
19
Median 3Y
16.2
Median 5Y
20
Industry
19.3
vs History
3
vs Industry
19
Median 3Y
3.2
Median 5Y
3.3
Industry
2

Multiples Across Competitors

NATCOPHARM Competitors Multiples
Natco Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Natco Pharma Ltd
NSE:NATCOPHARM
247B INR 5.8 15.1 11.4 12.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
771.1B USD 18.9 92.1 49.5 55.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35.3 24.5 28
US
Johnson & Johnson
NYSE:JNJ
368.9B USD 4.2 25.1 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
157.3B GBP 4.1 31 169.2 253.5
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
IN
Natco Pharma Ltd
NSE:NATCOPHARM
Average P/E: 31.2
15.1
-41%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.1
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.3
86%
US
Johnson & Johnson
NYSE:JNJ
25.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top